Mesenchymal Stem Cell Exosomes Promote Growth Plate Repair and Reduce Limb-Length Discrepancy in Young Rats

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Orthopedic Research

Background:

• Growth plate injuries in pediatric patients can lead to limb length discrepancies and deformities.
• Current treatments for growth plate injuries have limitations and can be invasive.
• Mesenchymal stromal/stem cells (MSCs) have shown therapeutic potential, but their use involves complex procedures.

Purpose of the Study:

• To evaluate the therapeutic efficacy of human MSC-derived exosomes in a rat model of growth plate injury.
• To determine if MSC exosomes can promote physeal repair and reduce limb length discrepancy.
• To assess the impact of MSC exosomes on cartilage regeneration and bone formation.

Main Methods:

• A surgical model of growth plate injury was created in Sprague-Dawley rats.
• Rats received a single intra-articular injection of MSC exosomes or phosphate-buffered saline (PBS) control.
• Limb length, tissue repair (histology, immunohistochemistry), and bone formation were assessed at 4 and 8 weeks post-treatment.

Main Results:

• MSC exosome treatment significantly increased limb length and reduced limb-length discrepancy compared to PBS controls.
• Exosome-treated defects showed increased chondrocyte density and deposition of sulphated glycosaminoglycan and collagen II.
• No significant inhibition of bone bridge formation was observed in either group.

Conclusions:

• A single injection of MSC exosomes effectively promotes physeal repair and reduces limb length discrepancy after growth plate injury.
• MSC exosomes represent a promising cell-free therapeutic approach for managing growth plate injuries.
• Further research is warranted to explore the clinical application of MSC exosomes in pediatric orthopedics.